Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic Article Swipe
Bradley D. Stein
,
Brendan Saloner
,
Flora Sheng
,
Mark Sorbero
,
Andrew W. Dick
,
Adam J. Gordon
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1007/s11606-024-09188-6
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1007/s11606-024-09188-6
Importance State policies facilitating telehealth implemented early in COVID may support buprenorphine treatment of opioid use disorder. However, little empirical information is available about those policies’ effects. Objective Examine association between state policies that may facilitate telehealth use and buprenorphine treatment. Design, Setting, Participants Retrospective cohort study using 2019–2020 national pharmacy data on dispensed buprenorphine prescriptions. Exposures State policies implemented after March 3, 2020, public health emergency declaration requiring private insurers’ telehealth reimbursement to be commensurate with in-person service reimbursement, authorizing Medicaid reimbursement for audio-only telehealth, allowing physicians to provide cross-state telehealth services, and allowing psychologists to provide cross-state telehealth services. Main Outcomes and Measures (a) Duration of treatment episodes started between March 1 and March 13 in both 2019 and 2020, and (b) daily numbers of new buprenorphine treatment episodes from March 13 through December 31 in each year. Key Results We found little change in the number of new buprenorphine treatment episodes started in 2020 compared to 2019 and an increase in treatment duration of 10.3 days (95%CI 8.3 to 12.2 days) for episodes started in March 2020 before the public health emergency declaration compared to the comparable 2019 period. States implementing a telehealth parity policy in 2020 had 7.3% (95%CI − 13.3% to − 0.4%) fewer new buprenorphine treatment episodes. States joining the psychologist interstate compact in 2020 after the public health emergency declaration had treatment episodes 7.97 days longer (95%CI 0.78 to 15.16) than other states. None of the other policies examined was associated with changes in new treatment episodes or treatment duration. Conclusions and Relevance Policies undertaken during the pandemic we examined were associated with few significant changes in buprenorphine treatment initiation and duration. Findings suggest realizing the benefits of telehealth and other policy changes for buprenorphine may require more extensive implementation and infrastructure support.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1007/s11606-024-09188-6
- OA Status
- hybrid
- References
- 56
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4404372253
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4404372253Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1007/s11606-024-09188-6Digital Object Identifier
- Title
-
Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID PandemicWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-11-14Full publication date if available
- Authors
-
Bradley D. Stein, Brendan Saloner, Flora Sheng, Mark Sorbero, Andrew W. Dick, Adam J. GordonList of authors in order
- Landing page
-
https://doi.org/10.1007/s11606-024-09188-6Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1007/s11606-024-09188-6Direct OA link when available
- Concepts
-
Telehealth, Buprenorphine, Medicine, Reimbursement, Telemedicine, Dispensary, Public health, Medical prescription, Medicaid, Declaration, Health care, Emergency medicine, Family medicine, Nursing, Opioid, Internal medicine, Economics, Economic growth, Political science, Law, ReceptorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
56Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4404372253 |
|---|---|
| doi | https://doi.org/10.1007/s11606-024-09188-6 |
| ids.doi | https://doi.org/10.1007/s11606-024-09188-6 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39543071 |
| ids.openalex | https://openalex.org/W4404372253 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000627 |
| mesh[1].descriptor_ui | D002047 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | therapeutic use |
| mesh[1].descriptor_name | Buprenorphine |
| mesh[2].qualifier_ui | Q000008 |
| mesh[2].descriptor_ui | D002047 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | administration & dosage |
| mesh[2].descriptor_name | Buprenorphine |
| mesh[3].qualifier_ui | Q000453 |
| mesh[3].descriptor_ui | D000086382 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | epidemiology |
| mesh[3].descriptor_name | COVID-19 |
| mesh[4].qualifier_ui | Q000331 |
| mesh[4].descriptor_ui | D017216 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | legislation & jurisprudence |
| mesh[4].descriptor_name | Telemedicine |
| mesh[5].qualifier_ui | Q000639 |
| mesh[5].descriptor_ui | D017216 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | trends |
| mesh[5].descriptor_name | Telemedicine |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D012189 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Retrospective Studies |
| mesh[7].qualifier_ui | Q000188 |
| mesh[7].descriptor_ui | D009293 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | drug therapy |
| mesh[7].descriptor_name | Opioid-Related Disorders |
| mesh[8].qualifier_ui | Q000453 |
| mesh[8].descriptor_ui | D009293 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | epidemiology |
| mesh[8].descriptor_name | Opioid-Related Disorders |
| mesh[9].qualifier_ui | Q000379 |
| mesh[9].descriptor_ui | D058850 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | methods |
| mesh[9].descriptor_name | Opiate Substitution Treatment |
| mesh[10].qualifier_ui | Q000453 |
| mesh[10].descriptor_ui | D014481 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | epidemiology |
| mesh[10].descriptor_name | United States |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006291 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Health Policy |
| mesh[12].qualifier_ui | Q000627 |
| mesh[12].descriptor_ui | D009292 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | therapeutic use |
| mesh[12].descriptor_name | Narcotic Antagonists |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D058873 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Pandemics |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D013219 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | State Government |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D015331 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Cohort Studies |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D006801 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Humans |
| mesh[17].qualifier_ui | Q000627 |
| mesh[17].descriptor_ui | D002047 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | therapeutic use |
| mesh[17].descriptor_name | Buprenorphine |
| mesh[18].qualifier_ui | Q000008 |
| mesh[18].descriptor_ui | D002047 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | administration & dosage |
| mesh[18].descriptor_name | Buprenorphine |
| mesh[19].qualifier_ui | Q000453 |
| mesh[19].descriptor_ui | D000086382 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | epidemiology |
| mesh[19].descriptor_name | COVID-19 |
| mesh[20].qualifier_ui | Q000331 |
| mesh[20].descriptor_ui | D017216 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | legislation & jurisprudence |
| mesh[20].descriptor_name | Telemedicine |
| mesh[21].qualifier_ui | Q000639 |
| mesh[21].descriptor_ui | D017216 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | trends |
| mesh[21].descriptor_name | Telemedicine |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D012189 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Retrospective Studies |
| mesh[23].qualifier_ui | Q000188 |
| mesh[23].descriptor_ui | D009293 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | drug therapy |
| mesh[23].descriptor_name | Opioid-Related Disorders |
| mesh[24].qualifier_ui | Q000453 |
| mesh[24].descriptor_ui | D009293 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | epidemiology |
| mesh[24].descriptor_name | Opioid-Related Disorders |
| mesh[25].qualifier_ui | Q000379 |
| mesh[25].descriptor_ui | D058850 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | methods |
| mesh[25].descriptor_name | Opiate Substitution Treatment |
| mesh[26].qualifier_ui | Q000453 |
| mesh[26].descriptor_ui | D014481 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | epidemiology |
| mesh[26].descriptor_name | United States |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D006291 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Health Policy |
| mesh[28].qualifier_ui | Q000627 |
| mesh[28].descriptor_ui | D009292 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | therapeutic use |
| mesh[28].descriptor_name | Narcotic Antagonists |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D058873 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Pandemics |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D013219 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | State Government |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D015331 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Cohort Studies |
| type | article |
| title | Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic |
| biblio.issue | 9 |
| biblio.volume | 40 |
| biblio.last_page | 1994 |
| biblio.first_page | 1986 |
| grants[0].funder | https://openalex.org/F4320307890 |
| grants[0].award_id | |
| grants[0].funder_display_name | RAND Corporation |
| topics[0].id | https://openalex.org/T10576 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2739 |
| topics[0].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[0].display_name | Opioid Use Disorder Treatment |
| topics[1].id | https://openalex.org/T10043 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9904999732971191 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | Substance Abuse Treatment and Outcomes |
| topics[2].id | https://openalex.org/T11860 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9882000088691711 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2713 |
| topics[2].subfield.display_name | Epidemiology |
| topics[2].display_name | HIV, Drug Use, Sexual Risk |
| funders[0].id | https://openalex.org/F4320307890 |
| funders[0].ror | https://ror.org/00f2z7n96 |
| funders[0].display_name | RAND Corporation |
| is_xpac | False |
| apc_list.value | 3790 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4690 |
| apc_paid.value | 3790 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 4690 |
| concepts[0].id | https://openalex.org/C2781050511 |
| concepts[0].level | 4 |
| concepts[0].score | 0.855520486831665 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q46994 |
| concepts[0].display_name | Telehealth |
| concepts[1].id | https://openalex.org/C2778949969 |
| concepts[1].level | 4 |
| concepts[1].score | 0.8378332257270813 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q407721 |
| concepts[1].display_name | Buprenorphine |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.8144668936729431 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2779703844 |
| concepts[3].level | 3 |
| concepts[3].score | 0.692857563495636 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q760125 |
| concepts[3].display_name | Reimbursement |
| concepts[4].id | https://openalex.org/C2779891985 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5698937773704529 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q46994 |
| concepts[4].display_name | Telemedicine |
| concepts[5].id | https://openalex.org/C2775959389 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5469754338264465 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q688829 |
| concepts[5].display_name | Dispensary |
| concepts[6].id | https://openalex.org/C138816342 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5354136824607849 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q189603 |
| concepts[6].display_name | Public health |
| concepts[7].id | https://openalex.org/C2426938 |
| concepts[7].level | 2 |
| concepts[7].score | 0.5252898931503296 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q3355478 |
| concepts[7].display_name | Medical prescription |
| concepts[8].id | https://openalex.org/C2776534028 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4892599284648895 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1141363 |
| concepts[8].display_name | Medicaid |
| concepts[9].id | https://openalex.org/C138147947 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4623365104198456 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1183659 |
| concepts[9].display_name | Declaration |
| concepts[10].id | https://openalex.org/C160735492 |
| concepts[10].level | 2 |
| concepts[10].score | 0.37842994928359985 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q31207 |
| concepts[10].display_name | Health care |
| concepts[11].id | https://openalex.org/C194828623 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3543761372566223 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q2861470 |
| concepts[11].display_name | Emergency medicine |
| concepts[12].id | https://openalex.org/C512399662 |
| concepts[12].level | 1 |
| concepts[12].score | 0.3390165865421295 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[12].display_name | Family medicine |
| concepts[13].id | https://openalex.org/C159110408 |
| concepts[13].level | 1 |
| concepts[13].score | 0.21607759594917297 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q121176 |
| concepts[13].display_name | Nursing |
| concepts[14].id | https://openalex.org/C2781063702 |
| concepts[14].level | 3 |
| concepts[14].score | 0.08798810839653015 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q427523 |
| concepts[14].display_name | Opioid |
| concepts[15].id | https://openalex.org/C126322002 |
| concepts[15].level | 1 |
| concepts[15].score | 0.07555872201919556 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[15].display_name | Internal medicine |
| concepts[16].id | https://openalex.org/C162324750 |
| concepts[16].level | 0 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q8134 |
| concepts[16].display_name | Economics |
| concepts[17].id | https://openalex.org/C50522688 |
| concepts[17].level | 1 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q189833 |
| concepts[17].display_name | Economic growth |
| concepts[18].id | https://openalex.org/C17744445 |
| concepts[18].level | 0 |
| concepts[18].score | 0.0 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[18].display_name | Political science |
| concepts[19].id | https://openalex.org/C199539241 |
| concepts[19].level | 1 |
| concepts[19].score | 0.0 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q7748 |
| concepts[19].display_name | Law |
| concepts[20].id | https://openalex.org/C170493617 |
| concepts[20].level | 2 |
| concepts[20].score | 0.0 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[20].display_name | Receptor |
| keywords[0].id | https://openalex.org/keywords/telehealth |
| keywords[0].score | 0.855520486831665 |
| keywords[0].display_name | Telehealth |
| keywords[1].id | https://openalex.org/keywords/buprenorphine |
| keywords[1].score | 0.8378332257270813 |
| keywords[1].display_name | Buprenorphine |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.8144668936729431 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/reimbursement |
| keywords[3].score | 0.692857563495636 |
| keywords[3].display_name | Reimbursement |
| keywords[4].id | https://openalex.org/keywords/telemedicine |
| keywords[4].score | 0.5698937773704529 |
| keywords[4].display_name | Telemedicine |
| keywords[5].id | https://openalex.org/keywords/dispensary |
| keywords[5].score | 0.5469754338264465 |
| keywords[5].display_name | Dispensary |
| keywords[6].id | https://openalex.org/keywords/public-health |
| keywords[6].score | 0.5354136824607849 |
| keywords[6].display_name | Public health |
| keywords[7].id | https://openalex.org/keywords/medical-prescription |
| keywords[7].score | 0.5252898931503296 |
| keywords[7].display_name | Medical prescription |
| keywords[8].id | https://openalex.org/keywords/medicaid |
| keywords[8].score | 0.4892599284648895 |
| keywords[8].display_name | Medicaid |
| keywords[9].id | https://openalex.org/keywords/declaration |
| keywords[9].score | 0.4623365104198456 |
| keywords[9].display_name | Declaration |
| keywords[10].id | https://openalex.org/keywords/health-care |
| keywords[10].score | 0.37842994928359985 |
| keywords[10].display_name | Health care |
| keywords[11].id | https://openalex.org/keywords/emergency-medicine |
| keywords[11].score | 0.3543761372566223 |
| keywords[11].display_name | Emergency medicine |
| keywords[12].id | https://openalex.org/keywords/family-medicine |
| keywords[12].score | 0.3390165865421295 |
| keywords[12].display_name | Family medicine |
| keywords[13].id | https://openalex.org/keywords/nursing |
| keywords[13].score | 0.21607759594917297 |
| keywords[13].display_name | Nursing |
| keywords[14].id | https://openalex.org/keywords/opioid |
| keywords[14].score | 0.08798810839653015 |
| keywords[14].display_name | Opioid |
| keywords[15].id | https://openalex.org/keywords/internal-medicine |
| keywords[15].score | 0.07555872201919556 |
| keywords[15].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1007/s11606-024-09188-6 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S116608325 |
| locations[0].source.issn | 0884-8734, 1525-1497 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0884-8734 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of General Internal Medicine |
| locations[0].source.host_organization | https://openalex.org/P4310319900 |
| locations[0].source.host_organization_name | Springer Science+Business Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319900 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of General Internal Medicine |
| locations[0].landing_page_url | https://doi.org/10.1007/s11606-024-09188-6 |
| locations[1].id | pmid:39543071 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of general internal medicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39543071 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:12325807 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Gen Intern Med |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12325807 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5030511819 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1544-458X |
| authorships[0].author.display_name | Bradley D. Stein |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1309849503 |
| authorships[0].affiliations[0].raw_affiliation_string | RAND Corporation, Pittsburgh, USA. [email protected]. |
| authorships[0].institutions[0].id | https://openalex.org/I1309849503 |
| authorships[0].institutions[0].ror | https://ror.org/00f2z7n96 |
| authorships[0].institutions[0].type | nonprofit |
| authorships[0].institutions[0].lineage | https://openalex.org/I1309849503 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | RAND Corporation |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Bradley D Stein |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | RAND Corporation, Pittsburgh, USA. [email protected]. |
| authorships[1].author.id | https://openalex.org/A5017119046 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9013-3023 |
| authorships[1].author.display_name | Brendan Saloner |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I145311948 |
| authorships[1].affiliations[0].raw_affiliation_string | Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. |
| authorships[1].institutions[0].id | https://openalex.org/I145311948 |
| authorships[1].institutions[0].ror | https://ror.org/00za53h95 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I145311948 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Johns Hopkins University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Brendan K Saloner |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. |
| authorships[2].author.id | https://openalex.org/A5075764338 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1511-6754 |
| authorships[2].author.display_name | Flora Sheng |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1309849503 |
| authorships[2].affiliations[0].raw_affiliation_string | RAND Corporation, Arlington, VA, USA. |
| authorships[2].institutions[0].id | https://openalex.org/I1309849503 |
| authorships[2].institutions[0].ror | https://ror.org/00f2z7n96 |
| authorships[2].institutions[0].type | nonprofit |
| authorships[2].institutions[0].lineage | https://openalex.org/I1309849503 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | RAND Corporation |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Flora Sheng |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | RAND Corporation, Arlington, VA, USA. |
| authorships[3].author.id | https://openalex.org/A5035567046 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8122-5732 |
| authorships[3].author.display_name | Mark Sorbero |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1309849503 |
| authorships[3].affiliations[0].raw_affiliation_string | RAND Corporation, Pittsburgh, USA. |
| authorships[3].institutions[0].id | https://openalex.org/I1309849503 |
| authorships[3].institutions[0].ror | https://ror.org/00f2z7n96 |
| authorships[3].institutions[0].type | nonprofit |
| authorships[3].institutions[0].lineage | https://openalex.org/I1309849503 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | RAND Corporation |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Mark Sorbero |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | RAND Corporation, Pittsburgh, USA. |
| authorships[4].author.id | https://openalex.org/A5049822685 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Andrew W. Dick |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1309849503 |
| authorships[4].affiliations[0].raw_affiliation_string | RAND Corporation, Boston, MA, USA. |
| authorships[4].institutions[0].id | https://openalex.org/I1309849503 |
| authorships[4].institutions[0].ror | https://ror.org/00f2z7n96 |
| authorships[4].institutions[0].type | nonprofit |
| authorships[4].institutions[0].lineage | https://openalex.org/I1309849503 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | RAND Corporation |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Andrew W Dick |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | RAND Corporation, Boston, MA, USA. |
| authorships[5].author.id | https://openalex.org/A5036614428 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-2453-8871 |
| authorships[5].author.display_name | Adam J. Gordon |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I223532165 |
| authorships[5].affiliations[0].raw_affiliation_string | Program for Addiction Research, Clinical Care, Knowledge and Advocacy, Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, USA. |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I4210089864 |
| authorships[5].affiliations[1].raw_affiliation_string | Informatics, Decision-Enhancement, and Analytic Sciences Center, VA Salt Lake City Health Care System, Salt Lake City, USA. |
| authorships[5].institutions[0].id | https://openalex.org/I223532165 |
| authorships[5].institutions[0].ror | https://ror.org/03r0ha626 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I223532165 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | University of Utah |
| authorships[5].institutions[1].id | https://openalex.org/I4210089864 |
| authorships[5].institutions[1].ror | https://ror.org/007fyq698 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I1322918889, https://openalex.org/I2799886695, https://openalex.org/I4210089864, https://openalex.org/I4210113540 |
| authorships[5].institutions[1].country_code | US |
| authorships[5].institutions[1].display_name | VA Salt Lake City Healthcare System |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Adam J Gordon |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Informatics, Decision-Enhancement, and Analytic Sciences Center, VA Salt Lake City Health Care System, Salt Lake City, USA., Program for Addiction Research, Clinical Care, Knowledge and Advocacy, Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, USA. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1007/s11606-024-09188-6 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2024-11-15T00:00:00 |
| display_name | Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10576 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2739 |
| primary_topic.subfield.display_name | Public Health, Environmental and Occupational Health |
| primary_topic.display_name | Opioid Use Disorder Treatment |
| related_works | https://openalex.org/W2385640725, https://openalex.org/W2416116201, https://openalex.org/W2408035333, https://openalex.org/W4290257406, https://openalex.org/W3025446869, https://openalex.org/W3032034513, https://openalex.org/W3024093514, https://openalex.org/W3024359715, https://openalex.org/W3025364260, https://openalex.org/W2292591203 |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1007/s11606-024-09188-6 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S116608325 |
| best_oa_location.source.issn | 0884-8734, 1525-1497 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0884-8734 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of General Internal Medicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310319900 |
| best_oa_location.source.host_organization_name | Springer Science+Business Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319900 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of General Internal Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.1007/s11606-024-09188-6 |
| primary_location.id | doi:10.1007/s11606-024-09188-6 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S116608325 |
| primary_location.source.issn | 0884-8734, 1525-1497 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0884-8734 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of General Internal Medicine |
| primary_location.source.host_organization | https://openalex.org/P4310319900 |
| primary_location.source.host_organization_name | Springer Science+Business Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319900 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of General Internal Medicine |
| primary_location.landing_page_url | https://doi.org/10.1007/s11606-024-09188-6 |
| publication_date | 2024-11-14 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W3014703200, https://openalex.org/W3048791385, https://openalex.org/W3095092064, https://openalex.org/W3118826438, https://openalex.org/W3109273728, https://openalex.org/W3164747366, https://openalex.org/W3126097640, https://openalex.org/W3138071933, https://openalex.org/W4389113546, https://openalex.org/W3033372292, https://openalex.org/W3144784433, https://openalex.org/W3158136047, https://openalex.org/W2313301965, https://openalex.org/W3214882210, https://openalex.org/W4319216411, https://openalex.org/W3115660820, https://openalex.org/W3188300554, https://openalex.org/W3141684473, https://openalex.org/W3112668148, https://openalex.org/W3112321879, https://openalex.org/W4311283097, https://openalex.org/W4206306026, https://openalex.org/W3164126346, https://openalex.org/W3196562351, https://openalex.org/W3081101017, https://openalex.org/W3208900020, https://openalex.org/W4386511143, https://openalex.org/W4295762238, https://openalex.org/W4304695145, https://openalex.org/W3173815853, https://openalex.org/W4293801899, https://openalex.org/W4317867629, https://openalex.org/W4223441176, https://openalex.org/W2808907017, https://openalex.org/W2943532942, https://openalex.org/W3165633131, https://openalex.org/W2801711697, https://openalex.org/W4380422574, https://openalex.org/W1964157254, https://openalex.org/W1970337515, https://openalex.org/W2990187794, https://openalex.org/W4388568260, https://openalex.org/W3025937663, https://openalex.org/W3095526646, https://openalex.org/W4384626051, https://openalex.org/W4315752884, https://openalex.org/W4361199807, https://openalex.org/W4288077275, https://openalex.org/W4323034978, https://openalex.org/W4386766744, https://openalex.org/W4286448022, https://openalex.org/W4400080376, https://openalex.org/W4392185526, https://openalex.org/W3153032010, https://openalex.org/W3106911145, https://openalex.org/W3119840752 |
| referenced_works_count | 56 |
| abstract_inverted_index.1 | 114 |
| abstract_inverted_index.a | 195 |
| abstract_inverted_index.13 | 117, 134 |
| abstract_inverted_index.3, | 63 |
| abstract_inverted_index.31 | 137 |
| abstract_inverted_index.We | 143 |
| abstract_inverted_index.an | 162 |
| abstract_inverted_index.be | 75 |
| abstract_inverted_index.in | 8, 118, 138, 147, 156, 164, 178, 199, 220, 251, 274 |
| abstract_inverted_index.is | 22 |
| abstract_inverted_index.of | 14, 108, 127, 150, 167, 242, 285 |
| abstract_inverted_index.on | 53 |
| abstract_inverted_index.or | 255 |
| abstract_inverted_index.to | 74, 89, 97, 159, 172, 188, 206, 236 |
| abstract_inverted_index.we | 266 |
| abstract_inverted_index.(a) | 106 |
| abstract_inverted_index.(b) | 124 |
| abstract_inverted_index.8.3 | 171 |
| abstract_inverted_index.Key | 141 |
| abstract_inverted_index.and | 39, 94, 104, 115, 121, 123, 161, 259, 278, 287, 298 |
| abstract_inverted_index.few | 271 |
| abstract_inverted_index.for | 84, 175, 291 |
| abstract_inverted_index.had | 201, 228 |
| abstract_inverted_index.may | 10, 35, 293 |
| abstract_inverted_index.new | 128, 151, 210, 252 |
| abstract_inverted_index.the | 148, 182, 189, 216, 223, 243, 264, 283 |
| abstract_inverted_index.use | 16, 38 |
| abstract_inverted_index.was | 247 |
| abstract_inverted_index.− | 204, 207 |
| abstract_inverted_index.0.78 | 235 |
| abstract_inverted_index.10.3 | 168 |
| abstract_inverted_index.12.2 | 173 |
| abstract_inverted_index.2019 | 120, 160, 191 |
| abstract_inverted_index.2020 | 157, 180, 200, 221 |
| abstract_inverted_index.7.3% | 202 |
| abstract_inverted_index.7.97 | 231 |
| abstract_inverted_index.Main | 102 |
| abstract_inverted_index.None | 241 |
| abstract_inverted_index.both | 119 |
| abstract_inverted_index.data | 52 |
| abstract_inverted_index.days | 169, 232 |
| abstract_inverted_index.each | 139 |
| abstract_inverted_index.from | 132 |
| abstract_inverted_index.more | 295 |
| abstract_inverted_index.than | 238 |
| abstract_inverted_index.that | 34 |
| abstract_inverted_index.were | 268 |
| abstract_inverted_index.with | 77, 249, 270 |
| abstract_inverted_index.0.4%) | 208 |
| abstract_inverted_index.13.3% | 205 |
| abstract_inverted_index.2020, | 64, 122 |
| abstract_inverted_index.COVID | 9 |
| abstract_inverted_index.March | 62, 113, 116, 133, 179 |
| abstract_inverted_index.State | 2, 58 |
| abstract_inverted_index.about | 24 |
| abstract_inverted_index.after | 61, 222 |
| abstract_inverted_index.daily | 125 |
| abstract_inverted_index.days) | 174 |
| abstract_inverted_index.early | 7 |
| abstract_inverted_index.fewer | 209 |
| abstract_inverted_index.found | 144 |
| abstract_inverted_index.other | 239, 244, 288 |
| abstract_inverted_index.state | 32 |
| abstract_inverted_index.study | 47 |
| abstract_inverted_index.those | 25 |
| abstract_inverted_index.using | 48 |
| abstract_inverted_index.year. | 140 |
| abstract_inverted_index.(95%CI | 170, 203, 234 |
| abstract_inverted_index.15.16) | 237 |
| abstract_inverted_index.States | 193, 214 |
| abstract_inverted_index.before | 181 |
| abstract_inverted_index.change | 146 |
| abstract_inverted_index.cohort | 46 |
| abstract_inverted_index.during | 263 |
| abstract_inverted_index.health | 66, 184, 225 |
| abstract_inverted_index.little | 19, 145 |
| abstract_inverted_index.longer | 233 |
| abstract_inverted_index.number | 149 |
| abstract_inverted_index.opioid | 15 |
| abstract_inverted_index.parity | 197 |
| abstract_inverted_index.policy | 198, 289 |
| abstract_inverted_index.public | 65, 183, 224 |
| abstract_inverted_index.Design, | 42 |
| abstract_inverted_index.Examine | 29 |
| abstract_inverted_index.Results | 142 |
| abstract_inverted_index.between | 31, 112 |
| abstract_inverted_index.changes | 250, 273, 290 |
| abstract_inverted_index.compact | 219 |
| abstract_inverted_index.joining | 215 |
| abstract_inverted_index.numbers | 126 |
| abstract_inverted_index.period. | 192 |
| abstract_inverted_index.private | 70 |
| abstract_inverted_index.provide | 90, 98 |
| abstract_inverted_index.require | 294 |
| abstract_inverted_index.service | 79 |
| abstract_inverted_index.started | 111, 155, 177 |
| abstract_inverted_index.states. | 240 |
| abstract_inverted_index.suggest | 281 |
| abstract_inverted_index.support | 11 |
| abstract_inverted_index.through | 135 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.December | 136 |
| abstract_inverted_index.Duration | 107 |
| abstract_inverted_index.Findings | 280 |
| abstract_inverted_index.However, | 18 |
| abstract_inverted_index.Measures | 105 |
| abstract_inverted_index.Medicaid | 82 |
| abstract_inverted_index.Outcomes | 103 |
| abstract_inverted_index.Policies | 261 |
| abstract_inverted_index.Setting, | 43 |
| abstract_inverted_index.allowing | 87, 95 |
| abstract_inverted_index.benefits | 284 |
| abstract_inverted_index.compared | 158, 187 |
| abstract_inverted_index.duration | 166 |
| abstract_inverted_index.effects. | 27 |
| abstract_inverted_index.episodes | 110, 131, 154, 176, 230, 254 |
| abstract_inverted_index.examined | 246, 267 |
| abstract_inverted_index.increase | 163 |
| abstract_inverted_index.national | 50 |
| abstract_inverted_index.pandemic | 265 |
| abstract_inverted_index.pharmacy | 51 |
| abstract_inverted_index.policies | 3, 33, 59, 245 |
| abstract_inverted_index.support. | 300 |
| abstract_inverted_index.Exposures | 57 |
| abstract_inverted_index.Objective | 28 |
| abstract_inverted_index.Relevance | 260 |
| abstract_inverted_index.available | 23 |
| abstract_inverted_index.disorder. | 17 |
| abstract_inverted_index.dispensed | 54 |
| abstract_inverted_index.duration. | 257, 279 |
| abstract_inverted_index.emergency | 67, 185, 226 |
| abstract_inverted_index.empirical | 20 |
| abstract_inverted_index.episodes. | 213 |
| abstract_inverted_index.extensive | 296 |
| abstract_inverted_index.in-person | 78 |
| abstract_inverted_index.realizing | 282 |
| abstract_inverted_index.requiring | 69 |
| abstract_inverted_index.services, | 93 |
| abstract_inverted_index.services. | 101 |
| abstract_inverted_index.treatment | 13, 109, 130, 153, 165, 212, 229, 253, 256, 276 |
| abstract_inverted_index.Importance | 1 |
| abstract_inverted_index.associated | 248, 269 |
| abstract_inverted_index.audio-only | 85 |
| abstract_inverted_index.comparable | 190 |
| abstract_inverted_index.facilitate | 36 |
| abstract_inverted_index.initiation | 277 |
| abstract_inverted_index.interstate | 218 |
| abstract_inverted_index.physicians | 88 |
| abstract_inverted_index.telehealth | 5, 37, 72, 92, 100, 196, 286 |
| abstract_inverted_index.treatment. | 41 |
| abstract_inverted_index.undertaken | 262 |
| abstract_inverted_index.2019–2020 | 49 |
| abstract_inverted_index.Conclusions | 258 |
| abstract_inverted_index.association | 30 |
| abstract_inverted_index.authorizing | 81 |
| abstract_inverted_index.cross-state | 91, 99 |
| abstract_inverted_index.declaration | 68, 186, 227 |
| abstract_inverted_index.implemented | 6, 60 |
| abstract_inverted_index.information | 21 |
| abstract_inverted_index.insurers’ | 71 |
| abstract_inverted_index.policies’ | 26 |
| abstract_inverted_index.significant | 272 |
| abstract_inverted_index.telehealth, | 86 |
| abstract_inverted_index.Participants | 44 |
| abstract_inverted_index.commensurate | 76 |
| abstract_inverted_index.facilitating | 4 |
| abstract_inverted_index.implementing | 194 |
| abstract_inverted_index.psychologist | 217 |
| abstract_inverted_index.Retrospective | 45 |
| abstract_inverted_index.buprenorphine | 12, 40, 55, 129, 152, 211, 275, 292 |
| abstract_inverted_index.psychologists | 96 |
| abstract_inverted_index.reimbursement | 73, 83 |
| abstract_inverted_index.implementation | 297 |
| abstract_inverted_index.infrastructure | 299 |
| abstract_inverted_index.prescriptions. | 56 |
| abstract_inverted_index.reimbursement, | 80 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| citation_normalized_percentile.value | 0.35178591 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |